Regulations.gov document
Agency Information Collection Activities; Announcement of OMB Approval; Adverse Experience…
Notice · FDA-2002-N-0304 · posted Jun 9, 2003
Key facts
| Document ID | FDA-2002-N-0304-0003 |
|---|---|
| Title | Agency Information Collection Activities; Announcement of OMB Approval; Adverse Experience Reporting for Licensed Biological Products; and General Records |
| Document type | Notice |
| Subtype | Notice of Approval |
| Agency | FDA |
| Docket | FDA-2002-N-0304 |
| Posted | Jun 9, 2003 |
| Federal Register citation | 68 FR 28235 |
| FR document number | 03-12920 |
| Comment period opens | May 23, 2003 |
| Effective date | May 16, 2003 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: